Marinus Pharmaceuticals Inc (MRNS)
1.79
+0.06
(+3.47%)
USD |
NASDAQ |
Oct 04, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
Marinus Pharmaceuticals Shareholders Equity (Annual): 16.76M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.76M |
| December 31, 2022 | 116.00M |
| December 31, 2021 | 53.49M |
| December 31, 2020 | 137.20M |
| December 31, 2019 | 87.77M |
| December 31, 2018 | 68.32M |
| Date | Value |
|---|---|
| December 31, 2017 | 58.01M |
| December 31, 2016 | 21.48M |
| December 31, 2015 | 46.92M |
| December 31, 2014 | 41.15M |
| December 31, 2013 | 9.458M |
| December 31, 2012 | 4.182M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
16.76M
Minimum
2023
137.20M
Maximum
2020
82.24M
Average
87.77M
Median
2019
Shareholders Equity (Annual) Benchmarks
| Chimerix Inc | 193.03M |
| Ocular Therapeutix Inc | 91.13M |
| Jaguar Health Inc | 4.961M |
| Seres Therapeutics Inc | -44.86M |
| PDS Biotechnology Corp | 26.13M |